Health TrialsbyHealthPanel

Invasive Group A Streptococcal Infection

ConditionsSepsis Due to Streptococcus, Group ARisk FactorsSevere InfectionMedical CareMedical ComplicationsOutcome, FatalTherapyStrainVirulence Factors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-17
SponsorAssociation Clinique Thérapeutique Infantile du val de Marne

About this trial

This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age<18 years

Documented invasive Group A Streptococcus infection (identification of GAS in a normally sterile site or from another site in case of toxin shock or necrotizing dermo-hypodermatitis)

Disqualifiers

Opposition of the patient or his/her legal representative

Trial population

Pediatrics patients with documented invasive infection due to Group A Streptococcus

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Hospitalisation

How long patient was hospitalised during this infection

Time frame
1 year
2

Treatments provided in intensive care unit

what treatments are used in intensive care unit to treat infection

Time frame
1 year
3

Complications

what are the complications due to severe infection

Time frame
1 year
4

Treatments used in routine care unit

which treatments are used in routine care unit to treat the infection

Time frame
1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Association Clinique Thérapeutique Infantile du val de Marne

Lead sponsor

Source ClinicalTrials.gov
Apply now